Randomized double blind placebo controlled study of sildenafil for treatment of serotonergic reuptake inhibitor associated sexual dysfunction in women with major depression treated to remission

Trial Profile

Randomized double blind placebo controlled study of sildenafil for treatment of serotonergic reuptake inhibitor associated sexual dysfunction in women with major depression treated to remission

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jul 2008

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Depression; Female sexual dysfunction; Sexual function disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jul 2008 Results have been published in the Journal of the American Medical Association.
    • 16 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top